Plasma cytokine and its tissue expression in different glucose tolerance persons

Plasma cytokine Is Associated With Insulin Resistance in Humans and Is Regulated by Hyperglycemia, Hyperinsulinemia, or Liraglutide Administration: Cross-sectional and interventional studies in normal subjects, insulin-resistant subjects, and subjects with newly diagnosed diabetes.

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCS-13003185

Enrollment

Unknown

Registered

2013-03-18

Start date

2013-05-15

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes and insulin resistance

Interventions

control:GLP-1 receptor agonist

Eligibility

Sex/Gender

All

Age

20 Years to 75 Years

Inclusion criteria

Inclusion criteria: Type 2 diabetes; Impaired glucose regulation;insulin resistant and non-insulin resistant people

Exclusion criteria

Exclusion criteria: Type 1 diabetes; diabetes with macro- and micro- vascular disease; overt proteinuria; urinary tract infection;serious dysfunction with heat, liver or kidney; recent MI or stroke or TIA

Design outcomes

Primary

Measure	Time frame
adipokine;blood sugar;lipids;BMI;	—

Countries

China

Contacts

Public ContactYang Gangyi

gangyiyang@yahoo.com.cn+86 13637796061

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 23, 2026